Corrigan Financial, Inc. Pfizer Inc Transaction History

Corrigan Financial, Inc.

$436 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Sep 01, 2023	BUY	$36.12 - $41.79 $288 - $334	8 Added 0.09%	8,891 $326 Million
Q1 2023 Sep 01, 2023	SELL	$39.39 - $51.28 $8,153 - $10,614	-207 Reduced 2.28%	8,883 $362 Million
Q4 2022 Sep 01, 2023	SELL	$41.75 - $54.5 $66,841 - $87,254	-1,601 Reduced 14.98%	9,090 $466 Million
Q3 2022 Sep 01, 2023	BUY	$43.76 - $53.42 $787 - $961	18 Added 0.17%	10,691 $468 Million
Q2 2022 Sep 01, 2023	SELL	$46.53 - $55.17 $175,650 - $208,266	-3,775 Reduced 26.13%	10,673 $560 Million
Q1 2022 Sep 01, 2023	BUY	$45.75 - $56.69 $174,216 - $215,875	3,808 Added 35.79%	14,448 $748 Million
Q4 2021 Sep 01, 2023	BUY	$41.32 - $61.25 $28,221 - $41,833	683 Added 6.86%	10,640 $628 Million
Q3 2021 Sep 01, 2023	SELL	$39.25 - $50.42 $7,418 - $9,529	-189 Reduced 1.86%	9,957 $428 Million
Q2 2021 Sep 01, 2023	BUY	$35.91 - $40.68 $502 - $569	14 Added 0.14%	10,146 $397 Million
Q1 2021 Sep 01, 2023	BUY	$33.49 - $37.77 $35,633 - $40,187	1,064 Added 11.73%	10,132 $367 Million
Q2 2020 Sep 01, 2023	SELL	$30.12 - $36.54 $2,831 - $3,434	-94 Reduced 1.03%	9,068 $297 Million
Q1 2020 Sep 01, 2023	SELL	$27.03 - $38.62 $1,000 - $1,428	-37 Reduced 0.4%	9,162 $299 Million
Q4 2019 Sep 01, 2023	SELL	$32.92 - $37.36 $86,019 - $97,621	-2,613 Reduced 22.12%	9,199 $360 Million
Q3 2019 Sep 01, 2023	BUY	$32.49 - $42.13 $84,474 - $109,538	2,600 Added 28.22%	11,812 $424 Million
Q2 2019 Sep 01, 2023	SELL	$36.98 - $41.52 $17,269 - $19,389	-467 Reduced 4.82%	9,212 $399 Million
Q1 2019 Aug 31, 2023	BUY	$37.5 - $41.2 $10,500 - $11,536	280 Added 2.98%	9,679 $411 Million
Q4 2018 Aug 31, 2023	BUY	$38.47 - $43.86 $18,119 - $20,658	471 Added 5.28%	9,399 $410 Million
Q3 2018 Aug 31, 2023	SELL	$34.47 - $41.81 $5,756 - $6,982	-167 Reduced 1.84%	8,928 $393 Million
Q2 2018 Aug 31, 2023	BUY	$32.98 - $35.16 $43,566 - $46,446	1,321 Added 16.99%	9,095 $330 Million
Q1 2018 Aug 31, 2023	BUY	$31.91 - $37.02 $21,603 - $25,062	677 Added 9.54%	7,774 $276 Million
Q4 2017 Aug 31, 2023	SELL	$33.26 - $35.29 $46,231 - $49,053	-1,390 Reduced 16.38%	7,097 $257 Million
Q3 2017 Aug 31, 2023	BUY	$31.0 - $34.15 $33,418 - $36,813	1,078 Added 14.55%	8,487 $303 Million
Q2 2017 Aug 31, 2023	BUY	N/A	784 Added 11.83%	7,409 $249 Million
Q4 2016 Aug 31, 2023	BUY	N/A	67 Added 1.02%	6,625 $215 Million
Q2 2016 Aug 30, 2023	SELL	N/A	-725 Reduced 9.95%	6,558 $231 Million
Q1 2016 Aug 30, 2023	BUY	N/A	545 Added 8.09%	7,283 $216 Million
Q4 2015 Aug 30, 2023	BUY	N/A	6,738	6,738 $0

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.6 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.2 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.66 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.32 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.43 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corrigan Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corrigan Financial, Inc. with notifications on news.

Account